A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?

Abstract:

:Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding imaging modality, thanks to the availability of compact medical cyclotrons and automated chemistry synthesis modules for the production of PET radiopharmaceuticals. Despite the availability of many radiotracers, [(18)F]fluorodeoxyglucose (FDG) is currently the most widely used radiopharmaceutical in PET, and the field of molecular imaging is anxiously awaiting the introduction of new PET radiopharmaceuticals for routine clinical use. During the last five years, several proprietary PET radiopharmaceuticals have been developed by major companies, and these new agents are in different stages of clinical evaluation. These new PET drugs are designed for imaging brain beta amyloid, myocardial perfusion, amino acid transport, angiogenesis, and tumor antigen expression. In addition, the National Cancer Institute, Society of Nuclear Medicine Clinical Trials Network, and the American College of Radiology Imaging Network have been conducting multicenter clinical trials with several nonproprietary PET drugs such as sodium [(18)F]fluoride, [(18)F]fluorothymidine, [(18)F]fluoromisonidazole, and (64)Cu-labeled diacetyl-bis (N(4)-methylthiosemicarbazone. All new PET radiopharmaceuticals, like any other drugs, must be manufactured under current good manufacturing practices as required by the Food and Drug Administration before clinical evaluation (phases I, II, and III) and submission of new drug application. This review briefly describes the chemistry, mechanisms(s) of localization, and clinical application of both proprietary and nonproprietary new PET drugs under multicenter clinical evaluation.

journal_name

Semin Nucl Med

authors

Vallabhajosula S,Solnes L,Vallabhajosula B

doi

10.1053/j.semnuclmed.2011.02.003

subject

Has Abstract

pub_date

2011-07-01 00:00:00

pages

246-64

issue

4

eissn

0001-2998

issn

1558-4623

pii

S0001-2998(11)00032-8

journal_volume

41

pub_type

杂志文章,评审
  • Evaluation of myocardial perfusion and function by single photon emission computed tomography.

    abstract::Although planar radionuclide techniques provide accurate, noninvasive measurements of myocardial perfusion and function that are of proven clinical value in the evaluation of the cardiac patient, they are limited by poor object contrast and superimposition of surrounding structures. Due to incomplete angular sampling ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(87)80034-x

    authors: Cerqueira MD,Harp GD,Ritchie JL

    更新日期:1987-07-01 00:00:00

  • Pathogen-Specific Bacterial Imaging in Nuclear Medicine.

    abstract::When serious infections are suspected, patients are often treated empirically with broad-spectrum antibiotics while awaiting results that provide information on the bacterial class and species causing the infection, as well as drug susceptibilities. For deep-seated infections, these traditional diagnostic techniques o...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2017.11.003

    authors: Ordonez AA,Jain SK

    更新日期:2018-03-01 00:00:00

  • A history of the American Board of Nuclear Medicine.

    abstract::The American Board of Nuclear Medicine gave its first certifying examination in 1972 to 1,096 candidates. It was established with the support of the Society of Nuclear Medicine amid considerable conflict involving the American Board of Radiology, the American Board of Internal Medicine, and the American Board of Patho...

    journal_title:Seminars in nuclear medicine

    pub_type: 历史文章,杂志文章

    doi:10.1016/s0001-2998(96)80024-9

    authors: Ross JF

    更新日期:1996-07-01 00:00:00

  • Gallium-68 EDTA PET/CT for Renal Imaging.

    abstract::Nuclear medicine renal imaging provides important functional data to assist in the diagnosis and management of patients with a variety of renal disorders. Physiologically stable metal chelates like ethylenediaminetetraacetic acid (EDTA) and diethylenetriamine penta-acetate (DTPA) are excreted by glomerular filtration ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2016.04.002

    authors: Hofman MS,Hicks RJ

    更新日期:2016-09-01 00:00:00

  • 15O-Water PET MPI: Current Status and Future Perspectives.

    abstract::Myocardial perfusion imaging with 15O-water positron emission tomography (PET) is a validated tool for quantitative measurement of myocardial blood flow (MBF) and myocardial flow reserve (MFR). Current scanner and software technology enable quantification of global and regional MBF in clinical PET myocardial perfusion...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2020.02.011

    authors: Maaniitty T,Knuuti J,Saraste A

    更新日期:2020-05-01 00:00:00

  • FDG-PET in prosthetic graft infections.

    abstract::Graft infection following prosthetic vascular reconstruction is an uncommon but severe complication. The clinical presentation is often subtle and nonspecific and may occur long after surgery. Although defining a prosthetic vascular graft infection can be difficult, early diagnosis and treatment are essential for the ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2013.04.004

    authors: Keidar Z,Nitecki S

    更新日期:2013-09-01 00:00:00

  • Bone and marrow imaging in sickle cell disease: diagnosis of infarction.

    abstract::Sickling of erythrocytes in patients with S-hemoglobin causes marrow and bone infarction. The former can be demonstrated as a lack of 99mTc-sulfur colloid uptake on marrow imaging examination. These defects may resolve or persist long after the acute episode. If the bone is involved in the acute episode, imaging withi...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(76)80038-4

    authors: Lutzker LG,Alavi A

    更新日期:1976-01-01 00:00:00

  • Radiopharmaceuticals for thrombus detection.

    abstract::Most of the components of the thrombotic and fibrinolytic systems have at some time been evaluated as a means of carrying a radiolabel specifically to thrombi, although very few have been promising enough to emerge from investigational status to routine clinical use. New approaches are being explored, including improv...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(05)80176-x

    authors: Knight LC

    更新日期:1990-01-01 00:00:00

  • Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors.

    abstract::The diphosphonate bone scan is ideally suited to assess many global, focal or multifocal metabolic bone disorders and there remains a role for conventional bone scintigraphy in metabolic bone disorders at diagnosis, investigation of complications, and treatment response assessment. In contrast, the role of bone scinti...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2009.08.002

    authors: Cook GJ,Gnanasegaran G,Chua S

    更新日期:2010-01-01 00:00:00

  • Software for image registration: algorithms, accuracy, efficacy.

    abstract::Image registration is finding increased clinical use both in aiding diagnosis and guiding therapy. There are numerous algorithms for registration, which all involve maximizing a measure of similarity between a transformed floating image and a fixed reference image. The choice of the similarity measure depends, to some...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/snuc.2003.127309

    authors: Hutton BF,Braun M

    更新日期:2003-07-01 00:00:00

  • Positron emission tomography/computed tomography for target delineation in head and neck cancers.

    abstract::Radiation and concurrent chemoradiation are essential in the treatment of head and neck cancers because they allow a potentially curative organ preservation approach in a manner that greatly affects quality of life. Greater doses of radiation to areas of gross disease have invariably led to greater loco-regional contr...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2007.11.002

    authors: Ahn PH,Garg MK

    更新日期:2008-03-01 00:00:00

  • Advances in the diagnosis and treatment of epilepsy.

    abstract::Epilepsy is the most common serious brain disorder in children, occurring in all parts of the world and within every stratum of the population. Through its effects, it exerts a significant physical, psychological, economic, and social toll on children and their caregivers. Historically, the surgical treatment of epile...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2012.06.005

    authors: Tamber MS,Mountz JM

    更新日期:2012-11-01 00:00:00

  • The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.

    abstract::In the past 20 years there have been great advances in our understanding of the molecular genetics of gastrointestinal tumors. In general, cancers develop and proliferate due to: driver mutations or related alterations in the genome resulting in overactivity of oncogenes, underactivity of tumor suppressor genes allowi...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2020.06.002

    authors: Wahl RL

    更新日期:2020-09-01 00:00:00

  • Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.

    abstract::FDG is a tracer for visualizing glucose metabolism. PET/CT using FDG is widely used for the diagnosis of cancer, because glycolysis is elevated in cancer cells. Similarly, active inflammatory tissue also exhibits elevated glucose metabolism because of glycolysis in activated macrophages and proliferating fibroblasts. ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2017.02.005

    authors: Kubota K,Yamashita H,Mimori A

    更新日期:2017-07-01 00:00:00

  • Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect.

    abstract::(18)F-fluorodeoxyglucose (FDG) is the radiotracer used in the vast majority of positron emission tomography (PET) cancer studies. FDG is a powerful radiotracer that provides valuable data in many cancer types. Normal FDG biodistribution is easily identified. In the PET-only era, physiological uptake provided important...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2010.02.001

    authors: Cohade C

    更新日期:2010-07-01 00:00:00

  • The role of parmacologic manipulation in adrenal cortical scintigraphy.

    abstract::Adrenal scintigraphy is a unique nuclear medicine procedure that provides noninvasive, functional information concerning the status of the adrenal cortex. The uptake of iodocholesterol, in addition to localizing adrenal cortical abnormalities, can be manipulate to focus on adrenal cortical dysfunction in either the al...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章

    doi:10.1016/s0001-2998(81)80042-6

    authors: Gross MD,Valk TW,Swanson DP,Thrall JH,Grekin RJ,Beirewaltes WH

    更新日期:1981-04-01 00:00:00

  • Radionuclide-labeled red blood cells: current status and future prospects.

    abstract::Radiolabeling of red cells and their clinical and research application in nuclear medicine constitute an area of continued interest and steady growth during the past two decades. Significant advances have been made so that at the present time, radiolabels with sufficient in vitro and in vivo stability are available fo...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(84)80022-7

    authors: Srivastava SC,Chervu LR

    更新日期:1984-04-01 00:00:00

  • Initial and subsequent approach for the synthesis of 18FDG.

    abstract::2-deoxy-2-[18F] fluoro-D-glucose (18FDG) was developed in 1976 in a collaboration between scientists at the National Institutes of Health, the University of Pennsylvania, and Brookhaven National Laboratory. It was developed for the specific purpose of mapping brain glucose metabolism in living humans, thereby serving ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/snuc.2002.29270

    authors: Fowler JS,Ido T

    更新日期:2002-01-01 00:00:00

  • Introduction to clinical decision making.

    abstract::In the last few years there has been a remarkable increase in the amount of clinical data in the average hospital chart, and more and more problem-solving algorithms have been developed. We need better "thinking tools" to help us handle the flow of information. The term "clinical decision making" is used to describe a...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章

    doi:10.1053/j.semnuclmed.2010.05.001

    authors: Patton DD

    更新日期:2010-09-01 00:00:00

  • The economics of creating a positron emission tomography center.

    abstract::Positron emission tomography (PET) scanning has been a powerful research tool since its inception. Changes in the marketplace that have allowed PET to move into the clinical environment include the commercial availability of appropriate radiopharmaceuticals, reimbursement of procedures by insurance companies, and incr...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章

    doi:10.1053/snuc.2000.9544

    authors: Lissak RJ

    更新日期:2000-10-01 00:00:00

  • Initial staging of lymphoma with positron emission tomography and computed tomography.

    abstract::Lymphomas represent a diverse range of diseases with manifold presentations, outlook, and therapeutic approaches. Key to the modern management of lymphoma is accurate delineation of the extent of disease. The inability of computed tomography (CT) to identify the involvement of nonenlarged nodes and its relatively poor...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2005.02.003

    authors: Hicks RJ,Mac Manus MP,Seymour JF

    更新日期:2005-07-01 00:00:00

  • Preclinical and clinical studies of peptide receptor radionuclide therapy.

    abstract::In the 1980s, the (111)In-labeled somatostatin analog OctreoScan (Covidien, Hazelwood, MO) was developed for imaging of somatostatin receptor subtype 2 (sst(2)) overexpressing tumors. On the basis of this success, peptide receptor radionuclide therapy (PRRT) was developed using similar somatostatin analogs with differ...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2009.12.001

    authors: Pool SE,Krenning EP,Koning GA,van Eijck CH,Teunissen JJ,Kam B,Valkema R,Kwekkeboom DJ,de Jong M

    更新日期:2010-05-01 00:00:00

  • Myocardial viability: it is still alive.

    abstract::Heart failure presents a significant problem in industrialized countries, with a high prevalence, morbidity, and mortality, where it is most frequently caused by coronary artery disease. Revascularization in patients with symptomatic heart failure has been associated with improved cardiovascular outcomes. Predictors o...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2014.07.003

    authors: Lim SP,Mc Ardle BA,Beanlands RS,Hessian RC

    更新日期:2014-09-01 00:00:00

  • An overview of the contribution of regional cerebral blood flow studies in cerebrovascular disease: is there a role for single photon emission computed tomography?

    abstract::Regional cerebral blood flow (rCBF) findings and their application to cerebrovascular disease are reviewed. Although the coupling of cerebral blood flow and metabolism are best studied with positron emission tomography, single-photon emission computed tomography measurements of rCBF can contribute to patient managemen...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(05)80236-3

    authors: Hellman RS,Tikofsky RS

    更新日期:1990-10-01 00:00:00

  • Trials and tribulations: oncological antibody imaging comes to the fore.

    abstract::At the present time, there are three radiolabeled antibodies that have been approved by the US Food and Drug Administration (FDA) for imaging of cancer, a fourth commercially sponsored product recommended for approval (as of 10/29/96, cap romab pendetide (ProstaScint; Cytogen Corp., Princeton, NJ) was upgraded from re...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(97)80033-5

    authors: Zuckier LS,DeNardo GL

    更新日期:1997-01-01 00:00:00

  • Nuclear endocrinology as a monitoring tool.

    abstract::Malignant endocrine disorders have been an enigma over the last few decades, from genetic, clinical, and imaging perspectives. The detection of the primary tumor and the identification of recurrent disease have been essentially based on various anatomic techniques, with localization procedures extensively developed fo...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/snuc.2001.23530

    authors: Krausz Y

    更新日期:2001-07-01 00:00:00

  • In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.

    abstract::The high-level expression of somatostatin receptors (SSTR) on various tumor cells has provided the molecular basis for successful use of radiolabeled peptide analogues as tumor tracers in nuclear medicine. The vast majority of human tumors seem to overexpress one or the other of 5 distinct hSSTR subtype receptors. Whe...

    journal_title:Seminars in nuclear medicine

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1053/snuc.2002.31565

    authors: Virgolini I,Britton K,Buscombe J,Moncayo R,Paganelli G,Riva P

    更新日期:2002-04-01 00:00:00

  • Functional renal imaging: new trends in radiology and nuclear medicine.

    abstract::The objective of this work is to compare the characteristics of various techniques for functional renal imaging, with a focus on nuclear medicine and magnetic resonance imaging. Even with low spatial resolution and rather poor signal-to-noise ratio, classical nuclear medicine has the advantage of linearity and good se...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2010.08.003

    authors: Durand E,Chaumet-Riffaud P,Grenier N

    更新日期:2011-01-01 00:00:00

  • Radionuclide therapy for osseous metastases in prostate cancer.

    abstract::Bone metastases are associated with increased morbidity and poor prognosis in castration-resistant prostate cancer. Since 2010, 5 systemic therapies for metastatic castration-resistant prostate cancer have been approved by the US Food and Drug Administration based on an improvement in overall survival, offering altern...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1053/j.semnuclmed.2014.07.006

    authors: Abi-Ghanem AS,McGrath MA,Jacene HA

    更新日期:2015-01-01 00:00:00

  • The use of personal computers in nuclear medicine.

    abstract::Consolidating personal computers (PCs) with nuclear medicine technology can create high computational power comparable with that produced by vendor-specific computer equipment, and at more affordable prices. The integration of a standard platform and operating system with a large installed base has enabled our departm...

    journal_title:Seminars in nuclear medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s0001-2998(05)80250-8

    authors: Tello R,Potter JE,Hill TC

    更新日期:1994-01-01 00:00:00